Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UK's BHF (British Heart Foundation) urges proper screening for OTC (over-the-counter) statin patients

This article was originally published in Clinica

Executive Summary

News as Clinica went to press that Merck's cholesterol-lowering drug, Zocor (simvastatin), is to be made available OTC in the UK has been given a guarded welcome by the British Heart Foundation, amid concerns that public access needs to be supported by appropriate testing and monitoring. Pending confirmation of how this might be ensured, the BHF called for "patients to be encouraged to accept the offer of reliable cholesterol checks", telling Clinica that testing measures would be an important element of the initiative.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT058504

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel